Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Combining the ladder with index funds adds diversification and steadier cash flow, helping manage sequence of return risk over retirement.
28,657 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...
A new study finds immigration restrictions don’t boost native workers and may hamper economic mobility for generation...
Two tech giants pull back in divergent fashion. This report analyzes valuations, AI upside, and cash flow to help ret...
PulteGroup accelerates its shift toward build-to-order homes to support margins as the 2026 housing market stays vola...
Zillow's latest forecast for 2026 hints at a shifting housing landscape. This guide breaks down what it means for mor...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...
A 68-year-old retiree taps a charitable remainder trust strategy to divest a $2.4 million concentrated stock position...
Five pivotal reverse mortgage stories from the first half of 2026 reveal how policy debates, consumer protections, an...
The U.S. Senate advanced a bipartisan housing reform package that includes a surprise CBDC ban through 2030. The move...
Starbucks still faces investor headwinds as revenue grows slowly and profitability remains pressured. A closer look a...
A Sunday morning design segment examines how style choices affect wallets—from backyard ADUs to luxury interiors—and ...